Sanjay actively advises companies with a focus and passion for innovative solution delivery to materially impact our Healthcare system. For a decade ending 2018, Sanjay served as Global President of the Toxicology division of Alere, Inc (NYSE: ALR), the Global market leader in diversified toxicology products, services and POC diagnostics. As the first-mover and consolidator, he grew the business from ~$50MM to ~$650MM, deployed over $1.3B in capital, led a stand-alone division of 2,500+ employees across all major world regions, and drove market-beating organic growth during his decade at Alere. As a member of the company’s executive team reporting to the CEO, he supported Alere’s $5.3 billion sale in 2017 to Abbott Laboratories, Inc (NYSE: ABT). Sanjay has executive experience across In Vitro Diagnostics, Healthcare Services and Information Solutions, and has developed the world-leading business in every healthcare category he has worked in. He held successive leadership positions in the Point-of-Care Diagnostics and Diabetes Care divisions of Roche Diagnostics, Inc. from 2001 to 2008, and within the Specialty Chemicals division of Dow Chemical, Inc. Sanjay has an MBA from Northwestern University, and an undergraduate degree in Industrial Engineering from Purdue University.